Drs. Dina Radenkovic and Bruna Paulsen are Co-Founder & CEO and VP of Manufacturing and Therapeutic development at Gameto, a biotech company developing treatment solutions to improve women’s reproductive health. Their lead platform, Fertilo, uses ovarian support cells to mature oocytes outside of the body with the goal of making IVF and egg freezing shorter, safer, and more effective.
Minimizing Off-Target Toxicity – Researchers identified carbonic anhydrase 12 as a druggable target for doxorubicin-induced cardiotoxicity.
Cell Division in Differentiation – Researchers have shown that cell state transitions are decoupled from cell division during early embryo development.
Images courtesy of Drs. Dina Radenkovic and Bruna Paulsen
Podden och tillhörande omslagsbild på den här sidan tillhör The Stem Cell Podcast. Innehållet i podden är skapat av The Stem Cell Podcast och inte av, eller tillsammans med, Poddtoppen.